CERO THERAPEUTICS HOLDINGS, INC. (CERO) Form 424B3 — May 29, 2026
$CEROForm 424B3Items 1.01, 2.03, 3.02, 9.01Filed May 29, 2026, 4:15 PM ET0001213900-26-062837Original filing
Cero Therapeutics Holdings, Inc. filed a prospectus supplement to update its S-1 registration statement with a Current Report on Form 8-K dated May 28, 2026. The update discloses the issuance of a convertible promissory note to SRX Health Solutions, Inc. The company sold the note for a purchase price of $750,000, which carries a principal face value of $937,500, effectively representing a 25% discount or original issue discount.
Key figures
- Debt Amount
- 937500
- Interest Rate
- 10
- Maturity Date
- 2027-05-28
- Offering Price
- 0.05
- Purchase price
- 750000
- Shares registered
- 729596950
- Conversion discount
- 80% of 5-day low
- Stock price at filing
- 0.0191
- Conversion price floor
- 0.05
- Warrant price at filing
- 0.0022
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.